Arcline Investment Management completed the acquisition of ChargePoint Technology.

Arcline Investment Management, a growth-oriented private equity firm, completed the acquisition of ChargePoint Technology, a manufacturer of containment and aseptic powder transfer technologies, primarily used in pharmaceutical manufacturing and bioprocessing applications. Financial terms were not disclosed. "We are excited to partner with Arcline, a firm that shares our passion for providing our customers with safer containment and sterile transfer technologies, which are critical to the future of medicine. We look forward to expanding our critical role in pharmaceutical manufacturing and bioprocessing as we invest in our next phase of growth," Chris Eccles, ChargePoint CEO.